Lumpectomy and radiation: improving the outcome
AS Lichter
JCO Mar 1 1992: 349–351. [PDF]
The purine analogs--a therapeutic beauty contest
BD Cheson
JCO Mar 1 1992: 352–355. [PDF]
	Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma
	DE Wazer, T DiPetrillo, R Schmidt-Ullrich, L Weld, TJ Smith, DJ Marchant, and NJ Robert
	JCO Mar 1 1992: 356–363. [Abstract] [PDF]
	2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia
	VM Santana, J Mirro, Jr, C Kearns, MJ Schell, W Crom, and RL Blakley
	JCO Mar 1 1992: 364–370. [Abstract] [PDF]
	2-Chlorodeoxyadenosine treatment of low-grade lymphomas
	AC Kay, A Saven, CJ Carrera, DA Carson, D Thurston, E Beutler, and LD Piro
	JCO Mar 1 1992: 371–377. [Abstract] [PDF]
	Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study
	GP Biti, G Cimino, C Cartoni, SM Magrini, AP Anselmo, RM Enrici, GP Bellesi, A Bosi, G Papa, and D Giannarelli
	JCO Mar 1 1992: 378–382. [Abstract] [PDF]
	Molecular and immunophenotypic characterization of AIDS-associated, Epstein-Barr virus-negative, polyclonal lymphoma
	B Shiramizu, B Herndier, T Meeker, L Kaplan, and M McGrath
	JCO Mar 1 1992: 383–389. [Abstract] [PDF]
	Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study
	DJ Hovgaard and NI Nissen
	JCO Mar 1 1992: 390–397. [Abstract] [PDF]
	Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte- macrophage colony-stimulating factor
	HM Kantarjian, M Talpaz, D Kontoyiannis, J Gutterman, MJ Keating, EH Estey, S O'Brien, MB Rios, M Beran, and A Deisseroth
	JCO Mar 1 1992: 398–405. [Abstract] [PDF]
	Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study
	R Grunewald, H Kantarjian, M Du, K Faucher, P Tarassoff, and W Plunkett
	JCO Mar 1 1992: 406–413. [Abstract] [PDF]
	Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma
	RA Figlin, A Belldegrun, N Moldawer, J Zeffren, and J deKernion
	JCO Mar 1 1992: 414–421. [Abstract] [PDF]
	Acquired von Willebrand disease in Wilms' tumor patients
	MJ Coppes, SW Zandvoort, CR Sparling, AO Poon, S Weitzman, and VS Blanchette
	JCO Mar 1 1992: 422–427. [Abstract] [PDF]
	Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients
	GM Clark, MC Mathieu, MA Owens, LG Dressler, L Eudey, DC Tormey, CK Osborne, KW Gilchrist, EG Mansour, and MD Abeloff
	JCO Mar 1 1992: 428–432. [Abstract] [PDF]
	Carboplatin: an active drug in metastatic breast cancer
	M Martin, E Diaz-Rubio, A Casado, P Santabarbara, JM Lopez Vega, E Adrover, and L Lenaz
	JCO Mar 1 1992: 433–437. [Abstract] [PDF]
	Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging
	P Bolufer, E Ricart, A Lluch, C Vazquez, A Rodriguez, A Ruiz, F Llopis, J Garcia- Conde, and R Romero
	JCO Mar 1 1992: 438–446. [Abstract] [PDF]
	Competing events determining relapse-free survival in limited small- cell lung carcinoma. The French Cancer Centers' Lung Group
	R Arriagada, A Kramar, T Le Chevalier, and H De Cremoux
	JCO Mar 1 1992: 447–451. [Abstract] [PDF]
	Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium
	EJ Dropcho, SS Rosenfeld, RB Morawetz, J Vitek, M Brothers, T Gorum, S Bell, GY Gillespie, M Glantz, and MS Mahaley, Jr
	JCO Mar 1 1992: 452–458. [Abstract] [PDF]
	Pulmonary function tests after whole-lung irradiation and doxorubicin in patients with osteogenic sarcoma
	ER Ellis, RB Marcus, Jr, MJ Cicale, DS Springfield, FJ Bova, J Graham-Pole, WF Enneking, SS Spanier, and RR Million
	JCO Mar 1 1992: 459–463. [Abstract] [PDF]
	Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose- intensive therapy
	TC Shea, JR Mason, AM Storniolo, B Newton, M Breslin, M Mullen, DM Ward, L Miller, M Christian, and R Taetle
	JCO Mar 1 1992: 464–473. [Abstract] [PDF]
	Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: a review article for surgeons, pathologists, and radiation and medical oncologists
	DH Clarke and AA Martinez
	JCO Mar 1 1992: 474–483. [Abstract] [PDF]
	Single-agent chemotherapy trials in small-cell lung cancer, 1970 to 1990: the case for studies in previously treated patients
	SC Grant, RJ Gralla, MG Kris, J Orazem, and EA Kitsis
	JCO Mar 1 1992: 484–498. [Abstract] [PDF]
	Hypercalcemia and neuroendocrine carcinoma of the prostate: a report of three cases and a review of the literature
	DC Smith, JA Tucker, and DL Trump
	JCO Mar 1 1992: 499–505. [Abstract] [PDF]
Ondansetron: confusing documentation surrounding an extrapyramidal reaction
BB Kanarek, R Curnow, J Palmer, and SF Cook
JCO Mar 1 1992: 506a–507. [PDF]
Irradiated blood products to prevent graft-versus-host disease
AB Whiteley
JCO Mar 1 1992: 506b. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.